Alpar HO - Search Results

1

Mechanisms of inactivation of HSV-2 during storage in frozen and lyophilized forms.

Hansen RK, Zhai S, Skepper JN, Johnston MD, Alpar HO, Slater NK. Hansen RK, et al. Among authors: alpar ho. Biotechnol Prog. 2005 May-Jun;21(3):911-7. doi: 10.1021/bp049601a. Biotechnol Prog. 2005. PMID: 15932273

2

Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1.

Shaw AE, Monaghan P, Alpar HO, Anthony S, Darpel KE, Batten CA, Guercio A, Alimena G, Vitale M, Bankowska K, Carpenter S, Jones H, Oura CA, King DP, Elliott H, Mellor PS, Mertens PP. Shaw AE, et al. Among authors: alpar ho. J Virol Methods. 2007 Nov;145(2):115-26. doi: 10.1016/j.jviromet.2007.05.014. Epub 2007 Jun 21. J Virol Methods. 2007. PMID: 17586061

3

Transfection by particle bombardment: delivery of plasmid DNA into mammalian cells using gene gun.

Uchida M, Li XW, Mertens P, Alpar HO. Uchida M, et al. Among authors: alpar ho. Biochim Biophys Acta. 2009 Aug;1790(8):754-64. doi: 10.1016/j.bbagen.2009.05.013. Epub 2009 May 27. Biochim Biophys Acta. 2009. PMID: 19477233

4

Biolistic transfection of human embryonic kidney (HEK) 293 cells.

Li X, Uchida M, Alpar HO, Mertens P. Li X, et al. Among authors: alpar ho. Methods Mol Biol. 2013;940:119-32. doi: 10.1007/978-1-62703-110-3_10. Methods Mol Biol. 2013. PMID: 23104338

5

Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles.

Li XW, Lee DK, Chan AS, Alpar HO. Li XW, et al. Among authors: alpar ho. Biochim Biophys Acta. 2003 Oct 20;1630(1):7-18. doi: 10.1016/j.bbaexp.2003.08.011. Biochim Biophys Acta. 2003. PMID: 14580674

6

Formulation of a microparticle carrier for oral polyplex-based DNA vaccines.

Howard KA, Li XW, Somavarapu S, Singh J, Green N, Atuah KN, Ozsoy Y, Seymour LW, Alpar HO. Howard KA, et al. Among authors: alpar ho. Biochim Biophys Acta. 2004 Sep 24;1674(2):149-57. doi: 10.1016/j.bbagen.2004.06.009. Biochim Biophys Acta. 2004. PMID: 15374619

7

Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies.

Cevher E, Salomon SK, Makrakis A, Li XW, Brocchini S, Alpar HO. Cevher E, et al. Among authors: alpar ho. J Microencapsul. 2015;32(8):755-68. doi: 10.3109/02652048.2015.1073392. Epub 2015 Aug 31. J Microencapsul. 2015. PMID: 26480961

8

Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.

Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S. Sayin B, et al. Among authors: alpar ho. Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9. Int J Pharm. 2008. PMID: 18662762

9

Development and characterisation of chitosan nanoparticles for siRNA delivery.

Katas H, Alpar HO. Katas H, et al. Among authors: alpar ho. J Control Release. 2006 Oct 10;115(2):216-25. doi: 10.1016/j.jconrel.2006.07.021. Epub 2006 Jul 25. J Control Release. 2006. PMID: 16959358

10

Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.

Kohli AK, Alpar HO. Kohli AK, et al. Among authors: alpar ho. Int J Pharm. 2004 May 4;275(1-2):13-7. doi: 10.1016/j.ijpharm.2003.10.038. Int J Pharm. 2004. PMID: 15081134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters